|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 2519 | Drugs / Medical | 07/07/2003
A class action has been filed against Piedmont Medical Center Hospital in Rock Hill, South Carolina, on behalf of all patients who were treated from January 1, 1997 to the eventual date of any judgment in the action, alleging that the Tenet Healthcare-owned facility overcharged them in violation of its own price gap contract provisions that are designed to keep it from being the most expensive hospital in the vicinity. The action seeks disgorgement of all profits that the hospital made from alleged overcharges.
Wade Comer alleges that Piedmont overcharged him $90,000 for medicine and services for his heart condition for at least four years, in violation of its contract with the local county. Among other things, he alleges that he was charged $40 for two milliliters of sterile water and $19 per blood sugar test, with as many as 20 tests in a day. The hospital was originally operated by York County as its general hospital until 1979. In 1980, it was sold to American Medical International, which was eventually purchased by Tenet, a 114-hospital chain based in Santa Barbara, California. In 1996, the contract between Tenet and the county allegedly included a price cap amendment that the hospital could not be the most expensive "among its peers." Ten local hospitals around the state were allegedly used as a benchmark. The action alleges that the amendment also required Piedmont to fix its prices if they are the highest. Piedmont allegedly charges an average 95 percent to 116 percent more than its nearest rival. Across the board, or the all-cases average, the hospital allegedly charged 33 percent more than the other hospitals. The action alleges that Piedmont's prices increased 113 percent between 1995 and 2001, while charges at a peer hospital in Charlotte, North Carolina, rose only 40 percent. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest Kahn Gauthier Swick is investigating possible legal actions against healthcare products firms Baxter International and Medisystems Corporation following the announcement that Baxter reported five deaths in kidney dialysis patients that may have been due to a particular combination of dialysis machine and blood tubing.
Several class actions have been filed against global medical products and services company Baxter International, Inc., (NYSE:BAX) and certain of its officers and directors by stockholders who purchased the company's common stock between April 19, 2001, and July 21, 2004. Also included, are all those who acquired Baxter's shares through its acquisitions of Autros, Fusion Medical, ESI Lederle, Acambis, Alpha-1, Cook Pharmaceutical, and Icodextrin, and present and former employees who purchased stock through Baxter's Retirement Savings Plans. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities.
State and federal privacy laws protect your confidential records from sale and use in many situations. A class action has been filed against CVS Corporation, Trio Drugs Corporation, and Manhattan pharmacist Gerald Hinderstein on behalf of pharmacy customers who allege that Trio and its pharmacist violated their fiduciary duties to their customers and committed deceptive business practices when they sold prescription drug records to CVS. Kahn Gauthier Swick, LLC ("KGS") announces that shareholders of Threshold Pharmaceuticals, Inc. ("Threshold" or the “Company”) (Nasdaq:THLD - News) who purchased shares of the Company between February 4, 2005 and July 14, 2006 (the "Class Period"), including purchasers of shares pursuant to Threshold’s February 4, 2005 Initial Public Offering (“IPO”) and its October 12, 2005 follow-on offering, have until September 4, 2007 to move for appointment as Lead Plaintiff in a securities class action lawsuit currently pending in the United States District Court for the Southern District of New York. No class has yet been certified in this action. Several class actions have been filed against drug manufacturer Ligand Pharmaceuticals, Inc. (Nasdaq:LGND), and certain of its officers and directors by stockholders who purchased the company's common stock between July 28, 2003, and August 2, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. When businesses try to collect debts, they must use their business names so consumers know to whom they are speaking. A class action has been filed against Lester E. Cox Medical Centers, Inc., and its debt collection division, Ozark Professional Collections, on behalf of patients who allege that the medical center misled them and other patients by collecting overdue payments through a fictitious third party in violation of the federal Fair Debt Collection Practices Act. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
